29/08/2026
To our AMET community,
In 2021, we co-founded AMET with a shared vision: a safer, more transparent aesthetic industry, where complications are met with support rather than stigma, and patient safety comes first.
We wanted you to hear it directly from us that Bronwyn has sold her share of AMET to Elena, who will continue to lead the organisation into its next chapter.
Bronwyn’s strategic insight, clinical experience and commitment to breaking down the stigma around adverse events have been fundamental to AMET since day one. Whilst this marks the end of a deeply meaningful chapter for her, it is also the start of an exciting new one still within the industry she’s helped shape.
Elena is immensely grateful for everything Bronwyn has put into AMET and honoured to keep building on everything they’ve created together. AMET’s purpose hasn’t changed, and there’s a lot still to come.
Since 2021, AMET has supported more than 350 adverse event cases and helped raise the standard of complication management across the industry; none of it possible without our Advisory Panel, Field Experts, Triage Team and, above all, our members.
Safer practitioners. Safer patients. A culture where complications can be discussed openly, managed appropriately, and used to improve standards across our industry.
To everyone who’s been part of this journey, thank you. Bronwyn is excited to watch AMET keep growing, and Elena wishes her every success in what comes next.
With sincere thanks,
Bronwyn Granata & Elena Currie
Co-Founders, AMET
Bronwyn RN.
Elena Currie RN
